JENNIFER BIGGS: Open Payments
NPI 1265739635 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 86 payments from 12 companies in 2025. Trend: 2023 $568 · 2024 $1,188 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $326 |
| Teva Pharmaceuticals USA, Inc. | 21 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $202 |
| Alkermes, Inc. | 8 | $177 |
| Janssen Pharmaceuticals, Inc | 8 | $160 |
| Vanda Pharmaceuticals Inc. | 5 | $91 |
| Neurocrine BioSciences, Inc. | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $47 |
| ABBVIE INC. | 2 | $35 |
Products named: COBENFY, CAPLYTA, ARISTADA, UZEDY, SPRAVATO, AUSTEDO XR, INGREZZA, REXULTI.
Industry payments across NC — which companies pay providers there.
